Cot? Orphan announced it will now provide CRO services that will help organizations navigate the clinical trials process
Coté Orphan, a regulatory affairs advisory firm specializing in orphan drugs, announced it will now provide CRO services that will help organizations navigate the clinical trials process through the lens of regulatory affairs. With the addition of the CRO services, Coté Orphan provides companies a complete and robust solution to those developing or seeking to develop orphan drugs.
